These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 35591891)
1. "Better to Die Than Take These Medicines": A Community-Based Qualitative Study on the Determinants of Treatment Loss-to-Follow-Up in Tuberculosis Patients in District Faridabad, Haryana, India. Khaitan A; Rai SK; Krishnan A; Gupta SK; Kant S; Khilnani GC Cureus; 2022 May; 14(5):e25030. PubMed ID: 35591891 [TBL] [Abstract][Full Text] [Related]
2. "I Would Rather Die Drinking than take the Medicine": Role of Alcohol Use Disorder in Loss-to-follow-up of Tuberculosis Treatment in a Rural Area of Ballabgarh, Haryana. Khaitan A; Rai SK; Krishnan A; Gupta SK; Kant S; Khilnani GC Indian J Community Med; 2024; 49(1):152-156. PubMed ID: 38425976 [TBL] [Abstract][Full Text] [Related]
3. Isoniazid mono-resistant tuberculosis: Time to take it seriously. Garg K; Saini V; Dhillon R; Agarwal P Indian J Tuberc; 2019 Apr; 66(2):247-252. PubMed ID: 31151492 [TBL] [Abstract][Full Text] [Related]
4. Why do patients with DR-TB do not complete their treatment? Findings of a qualitative study from Pakistan. Abubakar M; Ullah M; Shaheen MA; Abdullah O BMJ Open Respir Res; 2024 Feb; 11(1):. PubMed ID: 38413123 [TBL] [Abstract][Full Text] [Related]
5. Reasons for loss to follow-up (LTFU) of pulmonary TB (PTB) patients: A qualitative study among Saharia, a particularly vulnerable tribal group of Madhya Pradesh, India. Mishra P; Sharma RK; Yadav R; Rao VG; Nigam S; Lingala MA; Bhat J PLoS One; 2021; 16(12):e0261152. PubMed ID: 34941885 [TBL] [Abstract][Full Text] [Related]
6. Patient and Provider Reported Reasons for Lost to Follow Up in MDRTB Treatment: A Qualitative Study from a Drug Resistant TB Centre in India. Deshmukh RD; Dhande DJ; Sachdeva KS; Sreenivas A; Kumar AM; Satyanarayana S; Parmar M; Moonan PK; Lo TQ PLoS One; 2015; 10(8):e0135802. PubMed ID: 26301748 [TBL] [Abstract][Full Text] [Related]
7. Revisions in TB programme - boon or bane? A qualitative study exploring barriers and facilitators among health care workers in private and public sector, Kerala. Mathew G; Kumar SCS; Cherian KM; Issac N; Benjamin AI Indian J Tuberc; 2021 Jul; 68(3):356-362. PubMed ID: 34099201 [TBL] [Abstract][Full Text] [Related]
8. Incidence and predictors of lost to follow-up among drug-resistant tuberculosis patients at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia: a retrospective follow-up study. Kassa GM; Teferra AS; Wolde HF; Muluneh AG; Merid MW BMC Infect Dis; 2019 Sep; 19(1):817. PubMed ID: 31533661 [TBL] [Abstract][Full Text] [Related]
9. Determinant factors for loss to follow-up in drug-resistant tuberculosis patients: the importance of psycho-social and economic aspects. Soedarsono S; Mertaniasih NM; Kusmiati T; Permatasari A; Juliasih NN; Hadi C; Alfian IN BMC Pulm Med; 2021 Nov; 21(1):360. PubMed ID: 34758794 [TBL] [Abstract][Full Text] [Related]
10. A qualitative exploration of tuberculosis patients who were lost to follow-up in Malaysia. Tok PSK; Wong LP; Liew SM; Razali A; Mahmood MI; Chinnayah T; Kawatsu L; Toha HR; Mohd Yusof K; Abd Rahman R; Che Mat Din SNA; Loganathan T PLoS One; 2023; 18(9):e0289222. PubMed ID: 37676902 [TBL] [Abstract][Full Text] [Related]
11. Interpreting Mamelodi Community-Oriented Primary Care data on tuberculosis loss to follow-up through the lens of intersectionality. Ilunga BB; Eales OO; Marcus TS; Smith S; Hugo JF Afr J Prim Health Care Fam Med; 2020 Feb; 12(1):e1-e6. PubMed ID: 32129651 [TBL] [Abstract][Full Text] [Related]
12. Predictors of loss to follow-up among adult tuberculosis patients in Southern Ethiopia: a retrospective follow-up study. Watumo D; Mengesha MM; Gobena T; Gebremichael MA; Jerene D BMC Public Health; 2022 May; 22(1):976. PubMed ID: 35568853 [TBL] [Abstract][Full Text] [Related]
13. Self-driven solutions and resilience adapted by people with drug-resistant tuberculosis and their caregivers in Bengaluru and Hyderabad, India: a qualitative study. Nagarajan K; Kumarswamy K; Begum R; Panibatla V; Singarajipura A; Adepu R; Munjattu JF; Sellapan S; Arangba S; Goswami A; Swamickan R; Basha J; Dsouza PM; Muniyandi M Lancet Reg Health Southeast Asia; 2024 Mar; 22():100372. PubMed ID: 38420270 [TBL] [Abstract][Full Text] [Related]
14. TB patient support systems in Kerala: A qualitative analysis. George LS; Rakesh PS; Sunilkumar M; Vijayakumar K; Kunoor A; Kumar V A Indian J Tuberc; 2021 Jan; 68(1):9-15. PubMed ID: 33641857 [TBL] [Abstract][Full Text] [Related]
15. It's complicated: why do tuberculosis patients not initiate or stay adherent to treatment? A qualitative study from South Africa. Skinner D; Claassens M BMC Infect Dis; 2016 Nov; 16(1):712. PubMed ID: 27887646 [TBL] [Abstract][Full Text] [Related]
16. To study the impact of active case finding (ACF) among the TB patients detected in South Delhi. Shukla G; Sarin R; Vohra V; Khayyam KU Indian J Tuberc; 2021 Jan; 68(1):80-84. PubMed ID: 33641855 [TBL] [Abstract][Full Text] [Related]
17. 'They are inconveniencing us' - exploring how gaps in patient education and patient centred approaches interfere with TB treatment adherence: perspectives from patients and clinicians in the Free State Province, South Africa. Moodley N; Saimen A; Zakhura N; Motau D; Setswe G; Charalambous S; Chetty-Makkan CM BMC Public Health; 2020 Apr; 20(1):454. PubMed ID: 32252703 [TBL] [Abstract][Full Text] [Related]
18. Stakeholders' perceptions regarding a salt reduction strategy for India: Findings from qualitative research. Gupta P; Mohan S; Johnson C; Garg V; Thout SR; Shivashankar R; Krishnan A; Neal B; Prabhakaran D PLoS One; 2018; 13(8):e0201707. PubMed ID: 30080888 [TBL] [Abstract][Full Text] [Related]
19. Factors associated with Jiang Y; Chen J; Ying M; Liu L; Li M; Lu S; Li Z; Zhang P; Xie Q; Liu X; Lu H Front Med (Lausanne); 2023; 10():1136094. PubMed ID: 37181365 [TBL] [Abstract][Full Text] [Related]